Vijaya Diagnostic Centre Ltd
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]
- Market Cap ₹ 10,338 Cr.
- Current Price ₹ 1,007
- High / Low ₹ 1,277 / 629
- Stock P/E 78.1
- Book Value ₹ 69.8
- Dividend Yield 0.10 %
- ROCE 18.9 %
- ROE 17.2 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 14.4 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE Allcap BSE Healthcare Nifty 500 Multicap 50:25:25 Nifty Total Market Nifty 500
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|
238 | 279 | 329 | 367 | 451 | 450 | 525 | 608 | |
160 | 187 | 196 | 204 | 251 | 271 | 313 | 363 | |
Operating Profit | 78 | 92 | 133 | 163 | 200 | 179 | 212 | 246 |
OPM % | 33% | 33% | 40% | 44% | 44% | 40% | 40% | 40% |
5 | 9 | 12 | 11 | 13 | 15 | 19 | 17 | |
Interest | 4 | 4 | 15 | 15 | 16 | 21 | 24 | 24 |
Depreciation | 23 | 26 | 48 | 50 | 52 | 61 | 55 | 62 |
Profit before tax | 56 | 70 | 82 | 110 | 144 | 111 | 152 | 176 |
Tax % | 36% | 31% | 25% | 24% | 25% | 25% | 25% | |
35 | 49 | 61 | 83 | 108 | 83 | 115 | 132 | |
EPS in Rs | 78.17 | 108.02 | 135.13 | 18.28 | 10.60 | 8.15 | 11.20 | 12.91 |
Dividend Payout % | 0% | 0% | 0% | 0% | 9% | 12% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 13% |
TTM: | 21% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 8% |
TTM: | 18% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 31% |
1 Year: | 52% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 19% |
Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 10 |
Reserves | 162 | 211 | 273 | 356 | 460 | 535 | 643 | 706 |
26 | 36 | 156 | 137 | 183 | 248 | 250 | 265 | |
31 | 40 | 41 | 36 | 58 | 57 | 59 | 100 | |
Total Liabilities | 224 | 292 | 475 | 533 | 711 | 850 | 962 | 1,081 |
102 | 137 | 264 | 261 | 364 | 517 | 582 | 626 | |
CWIP | 3 | 3 | 10 | 9 | 34 | 28 | 9 | 16 |
Investments | 77 | 73 | 58 | 32 | 59 | 144 | 254 | 302 |
42 | 80 | 143 | 231 | 254 | 161 | 117 | 137 | |
Total Assets | 224 | 292 | 475 | 533 | 711 | 850 | 962 | 1,081 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
62 | 77 | 109 | 128 | 155 | 163 | 175 | |
-100 | -91 | -34 | -129 | -127 | -108 | -139 | |
-7 | 8 | -28 | -48 | -25 | -41 | -43 | |
Net Cash Flow | -44 | -7 | 46 | -49 | 4 | 13 | -8 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 14 | 14 | 9 | 7 | 8 | 7 | 9 |
Inventory Days | 24 | 19 | 23 | 16 | 22 | 12 | 26 |
Days Payable | 152 | 175 | 163 | 133 | 108 | 172 | 178 |
Cash Conversion Cycle | -115 | -142 | -130 | -110 | -79 | -153 | -143 |
Working Capital Days | -22 | -28 | -30 | -11 | -22 | -25 | -16 |
ROCE % | 33% | 27% | 27% | 28% | 18% | 19% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
26 Mar - Resignation of CFO Narasimha Raju KA effective March 26, 2025.
-
Closure of Trading Window
26 Mar - Trading window closure for designated persons.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 25 Mar
-
Notice Of Meeting Of The Unsecured Creditors Of Vijaya Diagnostic Centre Limited To Be Convened As Per The Directions Provided In The Order Of The Hon'Ble National Company Law Tribunal
25 Mar - Meeting of unsecured creditors for amalgamation approval.
-
Notice Of Meeting Of The Equity Shareholders Of Vijaya Diagnostic Centre Limited To Be Convened As Per The Directions Provided In The Order Of The Hon'Ble National Company Law Tribunal
25 Mar - Notice of meeting for scheme of amalgamation.
Annual reports
Concalls
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Dec 2023TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
Market Leadership
The company is the largest integrated diagnostic chain in South India. [1] It was among the first in South India to offer PET-CT scans. [2]